HLA-F Protein (AA 22-305) (His tag)

Produktnummer ABIN7123350

Produktdetails

Target: HLA-F (HLAF) (HLA Class I alpha F (HLAF))

Protein-Typ: Recombinant

Proteineigenschaft: AA 22-305

Spezies: Human

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses HLA-F Protein ist gelabelt mit His tag.

Applikation: ELISA, Western Blotting (WB)

Reinheit: Greater than 95 % as determined by SDS-PAGE

Sterilität: 0.2 μm filtered

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/mL in sterile distilled water by gentle pipetting 2-3 times, don't vortex

Buffer: Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5 % trehalose, pH 7.4

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: -20°C for 12 months as lyophilized, 2-8°C for 1 month under sterile conditions after reconstitution

Haltbarkeit: 12 months

Antigendetails

Target: HLA-F (HLAF) (HLA Class I alpha F (HLAF))

Andere Bezeichnung: HLA F (HLAF Produkte)

Synonyme: HLAF Protein, CDA12 Protein, HLA-5.4 Protein, HLA-CDA12 Protein, major histocompatibility complex, class I, F Protein, HLA-F Protein

Hintergrund: CDA12, HLA 5.4, HLA class I histocompatibility antigen, alpha chain F, HLA class I molecule, HLA F antigen, HLA-CDA12, HLA-F, HLAF, HLAF_HUMAN, Leukocyte antigen F, MHC class I antigen F

Molekulargewicht: 31.1 kDa

UniProt: P30511

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process